Sheeba Irshad


Dr Irshad is an early career CRUK Clinician Scientist; and was appointed as the Clinical Deputy Head of King’s College London Research Unit Programme in 2017. Sheeba's research focuses on understanding the tumour -immune cross-talk within the tumour microenvironment of difficult to treat cancers. Sheeba is also the translational lead and coordinating investigator for a translational trial platform with biomarker endpoints (PHOENIX). PHOENIX is due to open at 10 UK centres in September 2019.